via www.medicalnewstoday.com
Cambridge scientists raise prospect of new generation of treatments after finding technique to limit development of biggest cause of dementia
Scientists have found a method which could potentially stop the growth of Alzheimer’s disease in its tracks, raising the prospect of a wave of new treatments for the condition.
A team at Cambridge University, working with partners in Sweden and Estonia, has identified a molecule which can block the progress of Alzheimer’s at a crucial stage in its development.
Not only is it the first time that experts have identified a means of breaking the cycle leading to the development of Alzheimer’s but they believe the technique could be used to identify other molecules as future treatments to curb the growth of the condition.
Charities hailed it as an “exciting” discovery.
More than 520,000 people in the UK are estimated to be living with Alzheimer’s, by far the most common cause of dementia.
Dementia-related conditions are already the biggest cause of death among women in Britain and only narrowly outranked by heart disease and cancer for men.
Alzheimer’s develops when proteins in the brain malfunction and then stick together into fibres. They in turn eventually form clusters called oligomers which are toxic to nerve cells.
The second stage of that process is believed to set off a chain reaction which multiplies the number of clusters, hastening the development of the most devastating effects.
Experts at the Centre for Misfolding Diseases in Cambridge’s Chemistry Department have identified that natural proteins called Brichos, can stick to the fibres preventing them merging with others and forming the damaging clusters, therefore limiting the effects.
They believe the method used could help them identify other so-called “chaperone molecules” which could attach themselves in a similar way raising the prospect of a new generation of treatments.
Read more: Alzheimer’s breakthrough: scientists home in on molecule which halts development of disease
The Latest on: Chaperone molecules
via Google News
The Latest on: Chaperone molecules
- A new way to treat severe obesityon February 28, 2021 at 4:00 pm
New research could pave the way for the treatment of early morbid familial obesity, a disease that affects four to six percent of people suffering from early severe obesity.
- Yellowing: The Plastic Equivalent Of A Sunburnon February 28, 2021 at 4:00 pm
Free radicals are atoms or molecules with unpaired electrons that are highly reactive. Even if the plastic is put away in a box in the basement for a long time, exposure to the sun before boxing ...
- Revolution Medicines IPO Reels In $238M to Take On RAS in Canceron February 11, 2021 at 4:00 pm
Revolution is developing small molecules to target two signaling ... A second protein, which Revolution calls a “chaperone,” is used to form a binding pocket for a drug. Revolution is ...
- Bringing bad proteins back into the foldon February 11, 2021 at 2:09 am
A study led by UT Southwestern has identified a mechanism that controls the activity of proteins known as chaperones, which guide proteins to fold into the right shapes. The findings, published online ...
- Lysosomal signaling molecules regulate longevity in Caenorhabditis eleganson February 2, 2021 at 4:00 pm
LBP-8 acts as a chaperone that helps carry lipds to the nucleus ... Here, we explored how lysosomes might generate signaling molecules that regulate aging by influencing nuclear transcription. We ...
- An engineered S1P chaperone attenuates hypertension and ischemic injuryon February 2, 2021 at 4:00 pm
See allHide authors and affiliations The lipid mediator sphingosine 1-phosphate (S1P) is ferried in the blood by different chaperone proteins, the identity of which determines the specific signaling ...
- Molecular Biophysics: Titin, Actin, Myosinon August 18, 2020 at 10:11 am
Association of the chaperone alpha-B-crystallin with titin in heart muscle. J. Biol. Chem. 279:7917-7924. free pdf from publisher In the actomyosin in-vitro motility assay, fluorescently labeled actin ...
- Project 1:on October 13, 2019 at 5:24 am
We have identified ER chaperone BiP and mitochondrial chaperone mortalin as ... We use LPS inhalation and LPS-induced sepsis mouse models to address the in vivo significance of these molecules in the ...
- Naked antigen-presenting molecules on dendritic cellson September 16, 2019 at 5:38 am
In this case, does the invariant chain, expressed on the surface of several antigen-presenting cells, chaperone these MHC molecules to the surface before class II heterodimers form? In dendritic ...
- Heat shock protein-90alpha (Hsp90α) stabilizes hypoxia-inducible factor-1α (HIF-1α) in support of spermatogenesis and tumorigenesis | Cancer Gene Therapyon December 31, 1600 at 4:07 pm
Hypoxia-inducible factor-1 (HIF-1), a master transcriptional factor for protecting cells from hypoxia, plays a critical role in spermatogenesis and tumorigenesis. For the past two decades, numerous ...
via Bing News
